106 related articles for article (PubMed ID: 35247895)
1. Rules of Engagement: The Lymphocyte Receptor Ecosystem in Renal Cell Carcinoma.
Krishna C; Hakimi AA
Cancer Res; 2022 Mar; 82(5):764-765. PubMed ID: 35247895
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma.
Guo L; Bi X; Li Y; Wen L; Zhang W; Jiang W; Ma J; Feng L; Zhang K; Shou J
J Pathol; 2020 May; 251(1):26-37. PubMed ID: 32073142
[TBL] [Abstract][Full Text] [Related]
3. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
4. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
5. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.
Zhang Q; Jia Q; Deng T; Song B; Li L
Biochem Biophys Res Commun; 2015 Feb; 458(1):70-6. PubMed ID: 25637538
[TBL] [Abstract][Full Text] [Related]
7. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
Jantzer P; Schendel DJ
Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
9. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
Wang QJ; Hanada K; Robbins PF; Li YF; Yang JC
Cancer Res; 2012 Dec; 72(23):6119-29. PubMed ID: 23071066
[TBL] [Abstract][Full Text] [Related]
10. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA-seq data.
Li B; Li T; Wang B; Dou R; Zhang J; Liu JS; Liu XS
Nat Genet; 2017 Mar; 49(4):482-483. PubMed ID: 28358132
[No Abstract] [Full Text] [Related]
12. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression and infiltration by CD4
Lee HJ; Shin DH; Lee YJ; Lee SJ; Hwang CS; Kim A; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Park SW
Histopathology; 2020 Apr; 76(5):714-721. PubMed ID: 31841221
[TBL] [Abstract][Full Text] [Related]
14. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
Gerlinger M; Quezada SA; Peggs KS; Furness AJ; Fisher R; Marafioti T; Shende VH; McGranahan N; Rowan AJ; Hazell S; Hamm D; Robins HS; Pickering L; Gore M; Nicol DL; Larkin J; Swanton C
J Pathol; 2013 Dec; 231(4):424-32. PubMed ID: 24122851
[TBL] [Abstract][Full Text] [Related]
15. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.
Puisieux I; Bain C; Merrouche Y; Malacher P; Kourilsky P; Even J; Favrot M
Int J Cancer; 1996 Apr; 66(2):201-8. PubMed ID: 8603812
[TBL] [Abstract][Full Text] [Related]
16. Correlation of T Cell Immunoglobulin and ITIM Domain (TIGIT) and Programmed Death 1 (PD-1) with Clinicopathological Characteristics of Renal Cell Carcinoma May Indicate Potential Targets for Treatment.
Hong X; Wang X; Wang T; Zhang X
Med Sci Monit; 2018 Sep; 24():6861-6872. PubMed ID: 30262800
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
18. Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma.
Spassova I; Ugurel S; Terheyden P; Sucker A; Hassel JC; Ritter C; Kubat L; Habermann D; Farahpour F; Saeedghalati M; Peiffer L; Kumar R; Schrama D; Hoffmann D; Schadendorf D; Becker JC
Clin Cancer Res; 2020 May; 26(9):2257-2267. PubMed ID: 31932494
[TBL] [Abstract][Full Text] [Related]
19. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.
Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A
Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435
[TBL] [Abstract][Full Text] [Related]
20. Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma.
Kramer G; Steiner GE; Paiha S; Handisurya A; Djavan B; Mallone R; Marberger M
Eur Urol; 2001 Oct; 40(4):427-33. PubMed ID: 11713398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]